SCHEMBL6991740

SCHEMBL6991740

CN1C(=O)C(Br)=C(c2c(CCCc3[nH]c4ccccc4c3C3=C(Br)C(=O)N(C)C3=O)[nH]c3ccccc23)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP1A2 P05177 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 2/20 0.36
MPO P05164 4/20 0.36
CDK4 P11802 1/20 0.36
PRKACA P17612 1/20 0.36
PRKACG P22612 1/20 0.36
PRKACB P22694 1/20 0.36
CCND1 P24385 1/20 0.36
NPEPPS P55786 1/20 0.36
XDH P47989 2/20 0.36
CAMK2D Q13557 1/20 0.35
ROCK2 O75116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867603 0.97 GSK3B (0.44) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6860151 0.96 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6865292 0.96 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL7002332 0.96 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6864924 0.96 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867285 0.95 GSK3B (0.46) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867178 0.87 CTSV (0.41) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6865687 0.86 CTSV (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867979 0.84 HRH3 (0.39) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6955651 0.82 GSK3B (0.54) GSK3BSIRT2SIRT1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109785-B1 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ZENTARIS AG (DE) 2003-01-02 EP disclosed
EP-1109785-A2 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ASTA Medica Aktiengesellschaft (DE) 2001-06-27 EP disclosed
WO-1999057117-A2 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1999-11-11 WO disclosed